Shanghai Allist Pharmaceuticals Co. Ltd. A (688578) — Capital Reinvestment Ratio
Shanghai Allist Pharmaceuticals Co. Ltd. A (688578) has a Capital Reinvestment Ratio of 0.09x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥670.83 Million) in capital expenditures (CN¥63.68 Million). See debt-free asset ratio of Shanghai Allist Pharmaceuticals Co. Ltd. to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Shanghai Allist Pharmaceuticals Co. Ltd. A Capital Reinvestment Ratio (2017–2025)
This chart tracks Shanghai Allist Pharmaceuticals Co. Ltd. A's Capital Reinvestment Ratio across 6 annual periods. Check 688578 cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Shanghai Allist Pharmaceuticals Co. Ltd. A (2017–2025)
Year-by-year Capital Reinvestment Ratio for Shanghai Allist Pharmaceuticals Co. Ltd. A from 2017 to 2025. For live market cap and broader valuation context, see 688578 company net worth.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.08x | CN¥2.32 Billion | CN¥186.00 Million | ▼ -53.6% |
| 2024 | 0.17x | CN¥1.57 Billion | CN¥270.22 Million | ▲ +71.5% |
| 2023 | 0.10x | CN¥674.65 Million | CN¥67.88 Million | ▼ -93.6% |
| 2022 | 1.57x | CN¥91.63 Million | CN¥143.83 Million | ▼ -76.1% |
| 2021 | 6.56x | CN¥29.29 Million | CN¥192.25 Million | ▲ +4656.5% |
| 2017 | 0.14x | CN¥10.11 Million | CN¥1.40 Million | — |